Figure 1From: Optimal designs for population pharmacokinetic studies of the partner drugs co-administered with artemisinin derivatives in patients with uncomplicated falciparum malariaStructural pharmacokinetic models considered for the mefloquine optimal designs, with parameter values set to the reported population estimates. The optimal sampling windows are displayed on the time axes.Back to article page